Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.730615
Abstract: Perihilar cholangiocarcinoma (PHCCA) has a poor prognosis, mainly due to diagnosis at an advanced stage. Cripto-1 functions as an oncogene and is highly expressed in several human cancers, however, its clinical application in PHCCA is… read more here.
Keywords: exosomal cripto; biomarker; perihilar cholangiocarcinoma; cripto ... See more keywords